Alison Boyle is an Advanced BBV pharmacist in NHS Greater Glasgow and Clyde, Scotland. She has an MSc in Clinical Pharmacy and is a qualified independent prescriber. She also contributes to the content of the University of Liverpool drug interaction websites.

Dr. Havens is an ID epidemiologist whose research interests include characterizing the infectious complications of drug use in rural populations and HCV models of care in under-resourced Appalachian counties.

Dylan Vella-Horne is a Research Assistant at Burnet and a Public Health Master’s student. With over seven years of experience in supervised injecting facilities and supporting people who inject drugs, he specializes in blood-borne virus screening, treatment management, and harm reduction, with a strong focus on public health interventions.

Professor Peter Vickerman has 30 years’ experience of infectious disease modelling. His research focuses on using modelling to help understand the transmission of infectious diseases and impact/cost-effectiveness of prevention measures amongst key populations in different global settings, especially HIV and HCV among people who use drugs.

Shatyam Issur is a global health and human rights consultant, lecturer and policy advocate working at the intersection of law, public health, and advocacy. He brings expertise in HIV programming, harm reduction, intellectual property rights, and key population advocacy, with a strong focus on community-led approaches and structural reform. His work is guided by a deep commitment to advancing health equity, human rights, and inclusive development for historically marginalised communities. Shatyam's work spans over 15 countries, collaborating with grassroots groups, UN bodies, and global health institutions to decolonize funding, dismantle structural barriers, and empower communities — especially in contexts of HIV, Harm Reduction, and LGBTQ+ rights. From designing rights-based accountability programmes to leading capacity-building initiatives and advocating for legal reform, Shatyam combines legal acumen with strategic, policy and programmatic insight, and community-driven advocacy. Shatyam holds an LLM in Corporate Law and a BA (Hons) in Law and Criminal Justice, from the University of Mauritius and is currently completing a Master of Science (MSc) in Sexual and Reproductive Health Policy and Programming at the London School of Hygiene & Tropical Medicine (LSHTM). He is also an Atlantic (Senior) Fellow for Health Equity at the Milken Institute School of Public Health, George Washington University.

Siwaporn Niyomsri (Pharm.D., MSc) is a clinical pharmacist and health economist specializing in oncology and infectious diseases. Currently a Senior Research Associate at the University of Bristol. My work focuses on HCV, health economics, and policy research, particularly in LMICs and the UK.

Senior Consultant of Psychiatry/Addiction Medicine/Infectious Diseases. Medical Suprevisor for the Stockholm Needle and Syringe Programs, PhD Karolinska Institutet, Department of Global Public Health. Major area of research is within harm reduction, people who inject drugs, HIV/hepatitis C and overdose prevention.

Imen Farhat, a PhD student in epidemiology, focuses on equitable access to healthcare, particularly primary care. Her research examines how health systems can improve accessibility for vulnerable populations. With expertise in health administrative data analysis, she aims to generate evidence that informs policy and supports decision-making.

Rebekah Lamb has a professional background in public health, communicable disease and sexual health, and has worked in this sector for 9 years. With extensive experience in project management and health promotion, both in Australia and internationally, Bek has held several roles coordinating community-based-blood-borne virus programs and developing education programs.